Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT00304733
Other study ID # 2024
Secondary ID
Status Active, not recruiting
Phase N/A
First received March 16, 2006
Last updated March 16, 2006
Start date August 2001
Est. completion date April 2005

Study information

Verified date August 2001
Source Rehabilitation Centre Amsterdam
Contact n/a
Is FDA regulated No
Health authority Netherlands: Independent Ethics CommitteeNetherlands: Onze Lieve Vrouwe Gasthuis
Study type Interventional

Clinical Trial Summary

Objective: to compare the effectiveness of irremovable total contact casts and custom made temporary footwear to heal neuropathic foot ulcerations in individuals with diabetes


Description:

In this prospective clinical trail, 43 patients with plantar ulcer grade 1 or 2 (wagner scale) were randomized to one of two off-loading modalities: total contact cast or custom-made temporary footwear.outcomes assessed were wound surface area reduction (square cm.)and time to wound healing (days0 at 2,4,8 and 16 weeks. to evaluate safety, possible side effects were recorded at each follow-up visit.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 43
Est. completion date April 2005
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- confirmed diabetes

- neuropathic ulcer grade 1/2 (wagner scale)

- confirmed sensory neuropathy

Exclusion Criteria:

- osteomyelitis patients unable to walk

- life threatening co-morbidity ankle/brachial index , 0.4

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
cast vs. shoe


Locations

Country Name City State
Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam Noord Holland

Sponsors (3)

Lead Sponsor Collaborator
Rehabilitation Centre Amsterdam ConvaTec Inc., Ontwikkelingsfonds Orthopedisch maatschoeisel

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary wound surface area reduction
Secondary time to wound healing (days)